RankAlpha logo
Back to Rankings

MRKR

Marker TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
MRKR vs peer average
84/100
MRKR vs. peer average (B vs. D)
Grade spread
B 1 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ZYBT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $25.23M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerZYBTZhengye Biotechnology
MRKR
Marker Therapeutics
ZYBT
Zhengye Biotechnology
Grade
B
N/A
Momentum
74
79
Value
41
-
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Unrated
Open Side-by-Side ComparisonCompare all

Grade position vs ZYBT

MRKR / ZYBT
Grade Position
Above peers
MRKR vs. peer average (B vs. D)
84/100
Momentum
74
ZYBT
Value
41
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MRKR
1
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
N/A
-
-
2
VTGN
Vistagen Therapeutics Inc Common
F
20/100
+3
3
PTN
Palatin Technologies Inc Common
F
20/100
+3
4
PLUR
Pluri Inc Common
D
40/100
+2
5
TXMD
TherapeuticsMD Inc Common
B
80/100
Even
ZYBT is the first peer returned for this comparison set.